Decreased survival in patients with pulmonary engraftment syndrome following nonmyeloablative allogeneic hematopoietic cell transplantation (HCT).

被引:0
|
作者
Gorak, E
Geller, N
Srinivasan, R
Chakrabarti, S
Suffredini, A
Barrett, AJ
Childs, R
机构
[1] Walter Reed Army Med Ctr, Hematol Oncol Serv, Washington, DC 20307 USA
[2] NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA
[3] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
[4] NLBI, Hematol Branch, NIH, Bethesda, MD USA
[5] NIH, Ctr Clin, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1714
引用
收藏
页码:470A / 470A
页数:1
相关论文
共 50 条
  • [1] Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: Incidence and effects on survival
    Gorak, E
    Geller, N
    Srinivasan, R
    Espinoza-Delgado, I
    Donohue, T
    Barrett, AJ
    Suffredini, A
    Childs, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (07) : 542 - 550
  • [2] T-CELL ENGRAFTMENT KINETICS FOLLOWING MYELOABLATIVE AND NONMYELOABLATIVE REGIMENS FOR ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION
    Mickelson, D.
    Sproat, L.
    Dean, R.
    Sobecks, R.
    Rybicki, L.
    Kalaycio, M.
    Pohlman, B.
    Sweetenham, J.
    Andresen, S.
    Bolwell, B.
    Copelan, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 102 - 102
  • [3] Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning
    Baron, F
    Little, MT
    Storb, R
    BLOOD REVIEWS, 2005, 19 (03) : 153 - 164
  • [4] High-incidence of nephrotic syndrome associated with significant morbidity following nonmyeloablative allogeneic hematopoietic cell transplantation (HCT).
    Chakrabarti, S
    Balow, JE
    Srinivasan, R
    Igarashi, T
    Takahashi, Y
    Carvallo, C
    Marquesen, M
    Goodwin, R
    Barrett, AJ
    Childs, R
    BLOOD, 2003, 102 (11) : 726A - 727A
  • [5] Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children
    Nishio, Nobuhiro
    Yagasaki, Hiroshi
    Takahashi, Yoshiyuki
    Hama, Asahito
    Muramatsu, Hideki
    Tanaka, Makito
    Yoshida, Nao
    Yoshimi, Ayami
    Kudo, Kazuko
    Ito, Masafumi
    Kojima, Seiji
    PEDIATRIC TRANSPLANTATION, 2009, 13 (07) : 831 - 837
  • [6] Fludarabine pharmacokinetics in nonmyeloablative hematopoietic cell transplantation (HCT): Association with engraftment and neurotoxicty.
    Jacobson, PA
    Rogosheske, J
    Green, K
    Brunstein, C
    Barker, J
    Miller, J
    Wagner, J
    McGlave, P
    Tan, Y
    Weisdoff, D
    BLOOD, 2005, 106 (11) : 1023A - 1023A
  • [7] CHRONIC KIDNEY DYSFUNCTION FOLLOWING NONMYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
    Weiss, Andrew
    Storer, Barry
    Mcsweeney, Peter A.
    Sandmaier, Brenda M.
    Parikh, Chirag R.
    NEPHROLOGY, 2005, 10 : A34 - A35
  • [8] Engraftment syndrome following allogeneic hematopoietic cell transplantation: A retrospective review of 216 patients.
    Choi, SJ
    Lee, KH
    Lee, JH
    Kim, S
    Seol, M
    Lee, YS
    Kim, WK
    Lee, JS
    BLOOD, 2002, 100 (11) : 415A - 415A
  • [9] Pulmonary Engraftment Syndrome: A Unique Complication of Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis
    Amanam, Idoroenyi
    Otoukesh, Salman
    Yang, Dongyun
    Rahmanuddin, Syed
    Ball, Brian J.
    Al Malki, Monzr M.
    Nakamura, Ryotaro
    Marcucci, Guido
    Forman, Stephen J.
    Ali, Haris
    Pullarkat, Vinod A.
    BLOOD, 2022, 140 : 4726 - 4727
  • [10] Engraftment and survival following alternative donor allogeneic hematopoietic cell transplantation (HCT) with reduced intensity conditioning (RIC) for osteopetrosis.
    Grewal, SS
    Bonfim, CM
    Abel, SL
    Peters, C
    Ramsay, NKC
    Orchard, PJ
    BLOOD, 2003, 102 (11) : 431B - 432B